Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score

Chronic obstructive pulmonary disease (COPD), a leading cause of mortality and morbidity, presents significant challenges, particularly with exacerbations, which drastically impact patients' health and healthcare costs. The Global Initiative for Chronic Obstructive Lung Disease guidelines reco...

Full description

Bibliographic Details
Main Authors: Megha Hegde, Saurav Raj, Aishwarya S Pattanshetti, Sanatkumar Bharamu Nyamagoud
Format: Article
Language:English
Published: PAGEPress Publications 2024-03-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://www.monaldi-archives.org/macd/article/view/2955
_version_ 1797262015924797440
author Megha Hegde
Saurav Raj
Aishwarya S Pattanshetti
Sanatkumar Bharamu Nyamagoud
author_facet Megha Hegde
Saurav Raj
Aishwarya S Pattanshetti
Sanatkumar Bharamu Nyamagoud
author_sort Megha Hegde
collection DOAJ
description Chronic obstructive pulmonary disease (COPD), a leading cause of mortality and morbidity, presents significant challenges, particularly with exacerbations, which drastically impact patients' health and healthcare costs. The Global Initiative for Chronic Obstructive Lung Disease guidelines recommend comprehensive assessments beyond spirometry, with the COPD assessment test (CAT) emerging as a pivotal tool. Despite its utility, the relationship between CAT scores and specific biomarkers during exacerbations remains unclear. Hence, this study aims to assess the correlation between the CAT score and specific circulating biomarkers. A cross-sectional study from August 2023 to January 2024 included 59 COPD patients with exacerbations who underwent pulmonary function tests and completed the CAT score assessment. The CAT score cut-off point was set at 20, where a CAT score <20 indicated a low impact on health status and a CAT score ≥20 indicated a high impact on health status. On the same day, measurements of neutrophils, leukocytes, eosinophils, C-reactive protein, and procalcitonin were conducted. Patients with CAT scores ≥20 had significantly higher levels of neutrophils (p=0.001), leukocytes (p=0.006), procalcitonin (p=0.010), and forced expiratory volume in the first second/forced vital capacity (p=0.002), but lower eosinophil levels (p=0.025). A positive correlation existed between total CAT score and neutrophils (p=0.001), leukocytes (p=0.000), and procalcitonin (p=0.010), while eosinophil levels showed a negative correlation (p=0.025). The spirometry parameters showed no correlation with the total CAT score. This study highlights the link between CAT and key inflammatory biomarkers, supporting the use of blood biomarkers to identify COPD patients at risk of exacerbations.
first_indexed 2024-04-24T23:50:24Z
format Article
id doaj.art-fb1c21728dfb47cda80642e00052425e
institution Directory Open Access Journal
issn 1122-0643
2532-5264
language English
last_indexed 2024-04-24T23:50:24Z
publishDate 2024-03-01
publisher PAGEPress Publications
record_format Article
series Monaldi Archives for Chest Disease
spelling doaj.art-fb1c21728dfb47cda80642e00052425e2024-03-14T20:18:57ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642024-03-0110.4081/monaldi.2024.2955Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test scoreMegha Hegde0Saurav Raj1Aishwarya S Pattanshetti2Sanatkumar Bharamu Nyamagoud3Department of Pharmacy Practice, KLE College of Pharmacy, Hubli, KarnatakaDepartment of Pharmacy Practice, KLE College of Pharmacy, Hubli, KarnatakaHCG - KLE Suchirayu Hospital, Hubballi, KarnatakaDepartment of Pharmacy Practice, KLE College of Pharmacy, Hubli, Karnataka Chronic obstructive pulmonary disease (COPD), a leading cause of mortality and morbidity, presents significant challenges, particularly with exacerbations, which drastically impact patients' health and healthcare costs. The Global Initiative for Chronic Obstructive Lung Disease guidelines recommend comprehensive assessments beyond spirometry, with the COPD assessment test (CAT) emerging as a pivotal tool. Despite its utility, the relationship between CAT scores and specific biomarkers during exacerbations remains unclear. Hence, this study aims to assess the correlation between the CAT score and specific circulating biomarkers. A cross-sectional study from August 2023 to January 2024 included 59 COPD patients with exacerbations who underwent pulmonary function tests and completed the CAT score assessment. The CAT score cut-off point was set at 20, where a CAT score <20 indicated a low impact on health status and a CAT score ≥20 indicated a high impact on health status. On the same day, measurements of neutrophils, leukocytes, eosinophils, C-reactive protein, and procalcitonin were conducted. Patients with CAT scores ≥20 had significantly higher levels of neutrophils (p=0.001), leukocytes (p=0.006), procalcitonin (p=0.010), and forced expiratory volume in the first second/forced vital capacity (p=0.002), but lower eosinophil levels (p=0.025). A positive correlation existed between total CAT score and neutrophils (p=0.001), leukocytes (p=0.000), and procalcitonin (p=0.010), while eosinophil levels showed a negative correlation (p=0.025). The spirometry parameters showed no correlation with the total CAT score. This study highlights the link between CAT and key inflammatory biomarkers, supporting the use of blood biomarkers to identify COPD patients at risk of exacerbations. https://www.monaldi-archives.org/macd/article/view/2955COPDexacerbationbiomarkersCOPD assessment testCATcorrelation
spellingShingle Megha Hegde
Saurav Raj
Aishwarya S Pattanshetti
Sanatkumar Bharamu Nyamagoud
Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
Monaldi Archives for Chest Disease
COPD
exacerbation
biomarkers
COPD assessment test
CAT
correlation
title Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
title_full Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
title_fullStr Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
title_full_unstemmed Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
title_short Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
title_sort gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
topic COPD
exacerbation
biomarkers
COPD assessment test
CAT
correlation
url https://www.monaldi-archives.org/macd/article/view/2955
work_keys_str_mv AT meghahegde gaininginsightsintochronicobstructivepulmonarydiseaseexacerbationthroughemergingbiomarkersandthechronicobstructivepulmonarydiseaseassessmenttestscore
AT sauravraj gaininginsightsintochronicobstructivepulmonarydiseaseexacerbationthroughemergingbiomarkersandthechronicobstructivepulmonarydiseaseassessmenttestscore
AT aishwaryaspattanshetti gaininginsightsintochronicobstructivepulmonarydiseaseexacerbationthroughemergingbiomarkersandthechronicobstructivepulmonarydiseaseassessmenttestscore
AT sanatkumarbharamunyamagoud gaininginsightsintochronicobstructivepulmonarydiseaseexacerbationthroughemergingbiomarkersandthechronicobstructivepulmonarydiseaseassessmenttestscore